Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

280 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A reduced-toxicity regimen is associated with durable engraftment and clinical cure of nonmalignant genetic diseases among children undergoing blood and marrow transplantation with an HLA-matched related donor.
Mahadeo KM, Weinberg KI, Abdel-Azim H, Miklos DB, Killen R, Kohn D, Crooks GM, Shah AJ, Kharbanda S, Agarwal R, Kapoor N. Mahadeo KM, et al. Among authors: kharbanda s. Biol Blood Marrow Transplant. 2015 Mar;21(3):440-4. doi: 10.1016/j.bbmt.2014.11.005. Epub 2014 Nov 13. Biol Blood Marrow Transplant. 2015. PMID: 25459642 Free article. Clinical Trial.
Inflammatory cytokines and the development of pulmonary complications after allogeneic hematopoietic cell transplantation in patients with inherited metabolic storage disorders.
Kharbanda S, Panoskaltsis-Mortari A, Haddad IY, Blazar BR, Orchard PJ, Cornfield DN, Grewal SS, Peters C, Regelmann WE, Milla CE, Baker KS. Kharbanda S, et al. Biol Blood Marrow Transplant. 2006 Apr;12(4):430-7. doi: 10.1016/j.bbmt.2005.12.026. Biol Blood Marrow Transplant. 2006. PMID: 16545727 Free article. Clinical Trial.
Unrelated donor allogeneic hematopoietic stem cell transplantation for patients with hemoglobinopathies using a reduced-intensity conditioning regimen and third-party mesenchymal stromal cells.
Kharbanda S, Smith AR, Hutchinson SK, McKenna DH, Ball JB, Lamb LS Jr, Agarwal R, Weinberg KI, Wagner JE Jr. Kharbanda S, et al. Biol Blood Marrow Transplant. 2014 Apr;20(4):581-6. doi: 10.1016/j.bbmt.2013.12.564. Epub 2013 Dec 24. Biol Blood Marrow Transplant. 2014. PMID: 24370862 Free PMC article. Clinical Trial.
Improved outcomes after autologous bone marrow transplantation for children with relapsed or refractory Hodgkin lymphoma: twenty years experience at a single institution.
Garfin PM, Link MP, Donaldson SS, Advani RH, Luna-Fineman S, Kharbanda S, Porteus M, Weinberg KI, Agarwal-Hashmi R. Garfin PM, et al. Among authors: kharbanda s. Biol Blood Marrow Transplant. 2015 Feb;21(2):326-34. doi: 10.1016/j.bbmt.2014.10.020. Epub 2014 Oct 29. Biol Blood Marrow Transplant. 2015. PMID: 25445024 Free article.
A Multicenter Retrospective Analysis Stressing the Importance of Long-Term Follow-Up after Hematopoietic Cell Transplantation for β-Thalassemia.
Chaudhury S, Ayas M, Rosen C, Ma M, Viqaruddin M, Parikh S, Kharbanda S, Chiang KY, Haight A, Bhatia M, Guilcher G, Thompson A, Shenoy S. Chaudhury S, et al. Among authors: kharbanda s. Biol Blood Marrow Transplant. 2017 Oct;23(10):1695-1700. doi: 10.1016/j.bbmt.2017.06.004. Epub 2017 Jun 13. Biol Blood Marrow Transplant. 2017. PMID: 28627425 Free article.
The impact of total body irradiation-based regimens on outcomes in children and young adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.
Friend BD, Bailey-Olson M, Melton A, Shimano KA, Kharbanda S, Higham C, Winestone LE, Huang J, Stieglitz E, Dvorak CC. Friend BD, et al. Among authors: kharbanda s. Pediatr Blood Cancer. 2020 Feb;67(2):e28079. doi: 10.1002/pbc.28079. Epub 2019 Nov 14. Pediatr Blood Cancer. 2020. PMID: 31724815
280 results